<DOC>
	<DOCNO>NCT00538304</DOCNO>
	<brief_summary>A one month study determine safety efficacy bimatoprost eye drop patient glaucoma ocular hypertension</brief_summary>
	<brief_title>A Study Safety Efficacy Bimatoprost Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Chronic glaucoma ocular hypertension IOP control Xalatan Uncontrolled medical condition Known hypersensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>